Abstract
Fused deposition modeling (FDM) 3D printing has demonstrated high potential for the production of personalized medicines. However, the heating at high temperatures inherent to this process causes unknown risks to the drug product's stability. The present study aimed to assess the use of a tailored preformulation protocol involving physicochemical assessments, including the rheological profiles of the samples, to guide the development of medicines by FDM 3D printing. For this, polymers commonly used in FDM printing, i.e., high impact polystyrene (HIPS), polylactic acid (PLA), and polyvinyl alcohol (PVA), and their common plasticizers (mineral oil, triethyl citrate, and glycerol, respectively) were evaluated using the thermolabile model drug isoniazid (INH). Samples were analyzed by chemical and physical assays. The results showed that although the drug could produce polymorphs under thermal processing, the polymeric matrix can be a protective element, and no polymorphic transformation was observed. However, incompatibilities between materials might impact their chemical, thermal, and rheological performances. In fact, ternary mixtures of INH, PLA, and TEC showed a major alteration in their viscoelastic behavior besides the chemical changes. On the other hand, the use of plasticizers for HIPS and PVA exhibited positive consequences in drug solubility and rheologic behavior, probably improving sample printability. Thus, the optimization of the FDM 3D printing based on preformulation studies can assist the choice of compatible components and seek suitable processing conditions to obtain pharmaceutical products.
Graphical Abstract
Similar content being viewed by others
References
Gaisford S. 3D printed pharmaceutical products. In: Kalaskar DM, editor. 3D Printing in Medicine. Sawston: Woodhead Publishing; 2017. p. 155–166.
Araújo MRP, Sa-Barreto LL, Gratieri T, Gelfuso GM, Cunha-Filho M. The digital pharmacies era: How 3D printing technology using fused deposition modeling can become a reality. Pharmaceutics. 2019;11:128.
Cunha-Filho M, Araujo MR, Gelfuso GM, Gratieri T. FDM 3D printing of modified drug-delivery systems using hot melt extrusion: a new approach for individualized therapy. Ther Deliv. 2017;8:957–66.
Azad MA, Olawuni D, Kimbell G, Badruddoza AZM, Hossain MS, Sultana T. Polymers for extrusion-based 3D printing of pharmaceuticals: a holistic materials–process perspective. Pharmaceutics. 2020;12:124.
Viidik L, Vesala J, Laitinen R, Korhonen O, Ketolainen J, Aruväli J, et al. Preparation and characterization of hot-melt extruded polycaprolactone-based filaments intended for 3D-printing of tablets. Eur J Pharm Sci. 2021;158:105619.
Choi CH, Kim JI, Park JM. A 3D-printed patient-specific applicator guide for use in high-dose-rate interstitial brachytherapy for tongue cancer: A phantom study. Physi Med Biol. 2019;64:135002.
Zema L, Melocchi A, Maroni A, Gazzaniga A. Three-Dimensional Printing of Medicinal Products and the Challenge of Personalized Therapy. J Pharm Sci. 2017;106:1697–705.
Pires FQ, Alves-Silva I, Pinho LAG, Chaker JA, Sa-Barreto LL, Gelfuso GM, et al. Predictive models of FDM 3D printing using experimental design based on pharmaceutical requirements for tablet production. Int J Pharm. 2020;588:119728.
Censi R, Di Martino P. Polymorph impact on the bioavailability and stability of poorly soluble drugs. Molecules. 2015;20:18759–76.
Sadia M, Sośnicka A, Arafat B, Isreb A, Ahmed W, Kelarakis A, et al. Adaptation of pharmaceutical excipients to FDM 3D printing for the fabrication of patient-tailored immediate release tablets. Int J Pharm. 2016;513:659–68.
Pereira GG, Figueiredo S, Fernandes AI, Pinto JF. Polymer selection for hot-melt extrusion coupled to fused deposition modelling in pharmaceutics. Pharmaceutics. 2020;12:795.
Ilyés K, Kovács NK, Balogh A, Borbás E, Farkas BB, Casian T, et al. The applicability of pharmaceutical polymeric blends for the fused deposition modelling (FDM) 3D technique: Material considerations–printability–process modulation, with consecutive effects on in vitro release, stability and degradation. Eur J Pharm Sci. 2019;129:110–23.
Korte C, Quodbach J. Formulation development and process analysis of drug-loaded filaments manufactured via hot-melt extrusion for 3D-printing of medicines. Pharm Dev Technol. 2018;23:1117–27.
Nukala PK, Palekar S, Patki M, Patel K. Abuse deterrent immediate release egg-shaped tablet (Egglets) using 3D printing technology: quality by design to optimize drug release and extraction. AAPS PharmSciTech. 2019;20:80.
Ponsar H, Wiedey R, Quodbach J. Hot-Melt Extrusion Process Fluctuations and their Impact on Critical Quality Attributes of Filaments and 3D-printed Dosage Forms. Pharmaceutics. 2020;12:511.
Ghanizadeh Tabriz A, Nandi U, Hurt AP, Hui H-W, Karki S, Gong Y, et al. 3D printed bilayer tablet with dual controlled drug release for tuberculosis treatment. Int J Pharm. 2021;593:120147.
Genina N, Boetker JP, Colombo S, Harmankaya N, Rantanen J, Bohr A. Anti-tuberculosis drug combination for controlled oral delivery using 3D printed compartmental dosage forms: From drug product design to in vivo testing. J Control Release. 2017;268:40–8.
Öblom H, Zhang J, Pimparade M, Speer I, Preis M, Repka M, et al. 3D-printed isoniazid tablets for the treatment and prevention of tuberculosis—personalized dosing and drug release. AAPS PharmSciTech. 2019;20:1–13.
Keating AV, Soto J, Tuleu C, Forbes C, Zhao M, Craig DQM. Solid state characterisation and taste masking efficiency evaluation of polymer based extrudates of isoniazid for paediatric administration. Int J Pharm. 2018;536:536–46.
Maiza M, Benaniba MT, Quintard G, Massardier-Nageotte V. Biobased additive plasticizing Polylactic acid (PLA). Polimeros. 2015;25:581–90.
Lee M, Jung BN, Kim GH, Kang D, Park HJ, Shim JK, et al. The effect of triethyl citrate on the dispersibility and water vapor sorption behavior of polylactic acid/zeolite composites. Polym Test. 2020;89:106571.
LaFountaine JS, McGinity JW, Williams RO. Challenges and strategies in thermal processing of amorphous solid dispersions: a review. AAPS PharmSciTech. 2016;17:43–55.
Nasereddin JM, Wellner N, Alhijjaj M, Belton P, Qi S. Development of a simple mechanical screening method for predicting the feedability of a pharmaceutical FDM 3D printing filament. Pharm Res. 2018;35:151.
Gao JM, Ding LX, Hu CQ. A comparative uncertainty study of the purity assessment of chemical reference substances using differential scanning calorimetry (DSC) and mass balance method. Thermochim Acta. 2011;525:1–8.
Malaquias LFB, Schulte HL, Chaker JA, Karan K, Durig T, Marreto RN, et al. Hot melt extrudates formulated using design space: one simple process for both palatability and dissolution rate improvement. J Pharm Sci. 2017;107:286–96.
Daniel JSP, Cruz JC, Catelani TA, Garcia JS, Trevisan MG. Erythromycin-excipients compatibility studies using the thermal analysis and dynamic thermal infrared spectroscopy coupled with chemometrics. J Therm Anal Calorim. 2020;143:1–9.
Pires FQ, Pinho LA, Freire DO, Silva ICR, Sa-Barreto LL, Cardozo-Filho L, et al. Thermal analysis used to guide the production of thymol and Lippia origanoides essential oil inclusion complexes with cyclodextrin. J Therm Anal Calorim. 2019;137:543–53.
Nishimoto Y, Hattori Y, Otsuka M. Characterization of ternary amorphous solid dispersion containing hypromellose phthalate and erythritol prepared by hot melt extrusion using melting point depression. J Drug Delivery Sci Technol. 2020;58:101797.
Kennedy SR, Jones CD, Yufit DS, Nicholson CE, Cooper SJ, Steed JW. Tailored supramolecular gel and microemulsion crystallization strategies-is isoniazid really monomorphic? CrystEngComm. 2018;20:1390–8.
Zhang K, Fellah N, Shtukenberg AG, Fu X, Hu C, Ward MD. Discovery of new polymorphs of the tuberculosis drug isoniazid. CrystEngComm Royal Society of Chemistry. 2020;22:2705–8.
Bhutani H, Singh S, Vir S, Bhutani KK, Kumar R, Chakraborti AK, et al. LC and LC-MS study of stress decomposition behaviour of isoniazid and establishment of validated stability-indicating assay method. J Pharm Biomed Anal. 2007;43:1213–20.
Pessoa AS, Aguiar GPS, Vladimir Oliveira J, Bortoluzzi AJ, Paulino A, Lanza M. Precipitation of resveratrol-isoniazid and resveratrol-nicotinamide cocrystals by gas antisolvent. J Supercrit Fluids. 2019;145:93–102.
Afinjuomo F, Barclay TG, Parikh A, Chung R, Song Y, Nagalingam G, et al. Synthesis and characterization of pH-sensitive inulin conjugate of isoniazid for monocyte-targeted delivery. Pharmaceutics. 2019;11:555.
Carazo E, Cerezo P, Aguzzi C, Viseras C. Applied clay science adsorption and characterization of palygorskite-isoniazid nanohybrids. Appl Clay Sci. 2018;160:180–5.
Cunha-Filho MSS, Martínez-Pacheco R, Landín M, Cunha-filho SS, Landı M. Dissolution rate enhancement of the novel antitumoral β-lapachone by solvent change precipitation of microparticles. Eur J Pharm Biopharm. 2008;69:871–7.
Bochmann ES, Üstüner EE, Gryczke A, Wagner KG. Predicting melt rheology for hot-melt extrusion by means of a simple Tg-measurement. Eur J Pharm Biopharm. 2017;119:47–55.
Mashhadi SMA, Yufit D, Liu H, Hodgkinson P, Yunus U. Synthesis and structural characterization of cocrystals of isoniazid and cinnamic acid derivatives. J Mol Struct. 2020;1219:128621.
Farah S, Anderson DG, Langer R. Physical and mechanical properties of PLA, and their functions in widespread applications — A comprehensive review. Adv Drug Deliv Rev. 2016;107:367–92.
Wang L, Gramlich WM, Gardner DJ. Improving the impact strength of Poly(lactic acid) (PLA) in fused layer modeling (FLM). Polymer. 2017;114:242–8.
Ferreira-Nunes R, Gratieri T, Gelfuso GM, Cunha-Filho M. Mixture design applied in compatibility studies of catechin and lipid compounds. J Pharm Biomed Anal. 2018;149:612–7.
Stipa P, Marano S, Galeazzi R, Minnelli C, Mobbili G, Laudadio E. Prediction of drug-carrier interactions of PLA and PLGA drug-loaded nanoparticles by molecular dynamics simulations. Eur Polym J. 2021;147:110292.
Pires FQ, Angelo T, Silva JKR, Sá-Barreto LCL, Lima EM, Gelfuso GM, et al. Use of mixture design in drug-excipient compatibility determinations: Thymol nanoparticles case study. J Pharm Biomed Anal. 2017;137:196–203.
Bagchi S, Sharma K, Chakrabortty A, Lahiri SC. Spectrophotometric, FTIR and theoretical studies of the charge-transfer complexes between isoniazid (pyridine-4-carboxylic acid hydrazide) and the acceptors (p-chloranil, chloranilic acid and tetracyanoethylene) in acetonitrile, their association constant. Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy. 2012;95:637–47.
Pandey G, Yadav SK, Mishra B. Preparation and characterization of isoniazid and lamivudine co-loaded polymeric microspheres. Artificial Cells, Nanomedicine and Biotechnology. 2016;44:1867–77.
Oliveira PM, Matos BN, Pereira PAT, Gratieri T, Faccioli LH, Cunha-Filho MSS, et al. Microparticles prepared with 50–190 kDa chitosan as promising non-toxic carriers for pulmonary delivery of isoniazid. Carbohyd Polym. 2017;174:421–31.
Worzakowska M. Thermal and mechanical properties of polystyrene modified with esters derivatives of 3-phenylprop-2-en-1-ol. J Therm Anal Calorim. 2015;121:235–43.
Jang J, Lee DK. Plasticizer effect on the melting and crystallization behavior of polyvinyl alcohol. Polymer. 2003;44:8139–46.
Aho J, Genina N, Edinger M, Bøtker J, Baldursdóttir S, Rantanen J. Drug-loaded poly (-caprolactone) for 3D printing of personalized medicine : A rheological study. Proceedings of the 25th Nordic Rheology Conference. Helsinki, Finland; 2016. p. 97–100.
Gorain B, Choudhury H, Pandey M, Madheswaran T, Kesharwani P, Tekade RK. Drug-excipient interaction and incompatibilities. In: Tekade RK editor. Dosage form design parameters. Cambridge: Academic Press; 2018. p. 363–402.
Santos F, Branco LC, Duarte ARC. Organic salts based on isoniazid drug: Synthesis, bioavailability and cytotoxicity studies. Pharmaceutics. 2020;12:952.
Yang F, Su Y, Zhu L, Brown CD, Rosen LA, Rosenberg KJ. Rheological and solid-state NMR assessments of copovidone/clotrimazole model solid dispersions. Int J Pharm. 2016;500:20–31.
Isreb A, Baj K, Wojsz M, Isreb M, Peak M, Alhnan MA. 3D printed oral theophylline doses with innovative “radiator-like” design: Impact of polyethylene oxide (PEO) molecular weight. Int J Pharm. 2019;564:98–105.
Sadia M, Isreb A, Abbadi I, Isreb M, Aziz D, Selo A, et al. From “fixed dose combinations” to “a dynamic dose combiner”: 3D printed bi-layer antihypertensive tablets. Eur J Pharm Sci. 2018;123:484–94.
ACKNOWLEDGEMENTS
This research was supported by the Brazilian agencies FAP-DF (193.001.741/2017) and National Council for Scientific and Technological Development–CNPq (408291/2018-4).
Author information
Authors and Affiliations
Contributions
Ludmila A. G. Pinho: conceptualization, investigation, methodology, formal analysis, writing—original draft. Ana Luiza Lima: investigation, methodology, formal analysis, writing—original draft. Livia L. Sa-Barreto: conceptualization, resources, writing—review and editing. Tais Gratieri: conceptualization, resources, writing—review and editing. Guilherme M. Gelfuso: conceptualization, resources, writing—review and editing. Ricardo Neves Marreto: conceptualization, investigation, formal analysis, writing—review and editing. Marcilio Cunha-Filho: conceptualization, resources, supervision, project administration, investigation, formal analysis, resources, writing—review and editing. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing Interests
The authors declare that they have no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Theme: Novel Advances in 3-D Printing Technology in Drug Delivery
Rights and permissions
About this article
Cite this article
Pinho, L.A.G., Lima, A.L., Sa-Barreto, L.L. et al. Preformulation Studies to Guide the Production of Medicines by Fused Deposition Modeling 3D Printing. AAPS PharmSciTech 22, 263 (2021). https://doi.org/10.1208/s12249-021-02114-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1208/s12249-021-02114-7